INTEGRATED STUDIES, SCIENCE AND BUSINESS VALLEY SANTAKA CENTRE FOR THE ADVANCED PHARMACEUTICAL AND HEALTH TECHNOLOGIES.

Similar documents
MASTER IN PHARMACEUTICAL SCIENCES (Thesis Track)

National Academic Reference Standards (NARS) Pharmacy. January st Edition

Program of study. pharmacy. 1st year

The Centre of New Pharmaceutical and Health Technologies SANTAKA valley: research orientation towards entrepreneurship promotion

Pharmacy. i3l PHARMACY BACHELOR PROGRAM. The architect of drugs. Improving the Quality of Life

Saudi Pharmacist Licensure Examination (SPLE)

Content Areas of the Pharmacy Curriculum Outcomes Assessment (PCOA )

FIRST YEAR PHARM. D. Know about the theory and their application in pharmacy PDM107 Remedial Mathematics

Introduction to Drug Design and Discovery

NIH-RAID: A ROADMAP Program

What IMI means for POLAND

Program outcomes MPHARM. Demonstrate understanding of basic sciences relevant to specialty.

Higher National Diploma Biomedical Science

Main Content Domain % of Operational Items # of Operational Items

B.PHARMACY - SEMESTER I

Doctor of Pharmacy Course Descriptions

Diploma (Base Course) in Medicines Development

ADVANCES IN PHARMACEUTICAL INDUSTRY FOR WELLNESS AND SUSTAINABLE HEALTH

Pharmaceuticals and Biotechnology

Supplementary exam work (Number, form, scope) Courses (type of teaching) Contact time. Winter semester

ICH Topic Q 3 A Impurities Testing Guideline: Impurities in New Drug Substances

Concept of Integrated Research Platforms

List of E-journals Subscribed for the year 2016 (January to December) Pharmacy Faculty Sl. No.

Since 1996, UAP is the pioneer in launching four years Bachelor of Pharmacy (B. Pharm

Documentation requirements for an initial consultation

Master List of Professional Electives Course Title Description Credit Hours. Note: This class only meets for the last 7 class periods of the semester.

Medicine of the future: foresight

SHANGHAI MEDICILON INC.

Graduate Courses: Advanced Pharmaceutics Prerequisites: Course No: Instructor: Credits: Description:

Post-Baccalaureate Program in Pharmaceutical Science. Accelerate your career

Supplementary exam work (Number, form, scope) Courses (type of teaching) Contact time. Winter semester

What is biomedical science?

VICH Topic GL10. Step 7 (after revision at step 9) GUIDELINE ON IMPURITIES IN NEW VETERINARY DRUG SUBSTANCES

From Discovery to Development of new Drugs. and pitfalls along the way. by Kim Dekermendjian, PhD in Medicine BD & Key Account manager

DRUG REGISTRATION REGULATION

Guideline for the quality, safety and efficacy of follow-on biological medicinal products

EXPERT COLLECTION. Explore our leading medical review series

Program- Doctor of Pharmacy

Consultation by a notified body on an ancillary medicinal substance integrated in a medical device

REIMAGINING DRUG DEVELOPMENT:

'PHARMACOLOGY%20%26%20PHARMACY'

Basic Information. I.1 If your company performs biotechnology research and development, uses a. The Categories of Biotechnology Applications.

ICH Topic Q 3 B Impurities in New Medicinal Products

Week 1: Discovery Biology Basic knowledge and tools used in Research and Development

Guidelines for Pharmaceutical Equivalence Requirements

Quality & Safety GLP. 44 q&more 02/14

Biomedical Engineering

BIOTECH PARK, LUCKNOW TRAINING PROGRAMMES FOR STUDENTS

Guidance for Industry Q3B(R2) Impurities in New Drug Products

IMPURITIES IN NEW DRUG PRODUCTS

Regulatory Issues and Drug Product Approval for Biopharmaceuticals

Guidance for Industry

Pharmaceutical Sciences

Konica Minolta to Acquire Invicro (US)

No. Classification Credit Actual Hour/s. 1 Theoretical Component Lab. Component Clinical Component 1 3. Foundation Program

Mapping between Web of Science categories and 54 academic subjects

Projet EuCP European Certified Pharmacologists. Utrecht mars

DRUG REGISTRATION REGULATION

Stem cell and cell therapeutics research in Lithuania. Bernardas Morkunas Head of Business Development

synlab clinical trial

IK4 BIOTECHNOLOGY & BIOMATERIALS. Research Alliance.

Certification of qualified persons for pharmaceutical production conditions and requirements of the Eurasian Economic Union

Newcastle University Summer Congregations Monday 9 July Combined Honours Centre (1 of 2) BA Combined Honours (Year Abroad)

Drug Discovery and Development PHG 311. Prof. Dr. Amani S. Awaad

Toxicology - Problem Drill 24: Toxicology Studies in Pharmaceutical Development

UNLEASH THE POWER OF PRECISION MEDICINE

The science of transforming an Active Pharmaceutical Ingredient (API) into a Drug Product (DP) in a specific dosage form.

List of Upper Division Science Electives * = this course has prereqs purple highlight = special type of course

Pharmabiotics: a Regulatory Hurdle in Europe

Europe s Number One Medical Diagnostics Provider

Category Median Aggregate Aggregate Aggregate. Factor Factor Index Half-Life

ICH Topic M 4 Q Location issues for Common Technical Document for the Registration of Pharmaceuticals for Human Use Quality Questions and Answers

Microdose Radiopharmaceutical Diagnostic Drugs: Nonclinical Study Recommendations Guidance for Industry

DOWNLOAD OR READ : SAFETY EVALUATION TOXICOLOGY METHODS CONCEPTS AND RISK ASSESSMENT ADVANCES IN MODERN ENVIRONMENTAL TOXICOLOGY PDF EBOOK EPUB MOBI

Guideline on the non-clinical requirements for radiopharmaceuticals

Dermal drug testing. Pharmacokinetic, pharmacodynamic and bioequivalence studies in the dermis

Life SCIENCE GR ADUATE SCHOOL OF

Maximizing opportunities towards achieving clinical success D R U G D I S C O V E R Y. Report Price Publication date

INTRODUCTORY GUIDE TO CNS DRUG DISCOVERY

THE INNOVATION COMPANY HEALTH. Institute for Biomedicine and Health Sciences

MASTER S DEGREE IN BIOTECHNOLOGY AND MEDICAL BIOLOGY. Faculty of Medicine and Surgery

The Integrated Biomedical Sciences Graduate Program

The Review Section Table (Overview)

Institute of Pharmaceutical Technology and Biopharmacy University of Pécs szeptember 22. 1

From Bench to Bedside. Russ H. Read June 23, 2014

BIOSCIENTIA. Good outcomes are based on good values. Central lab services and biomarker analytics for clinical trials

From IMI to IMI2 new models of collaborative research. Magda Chlebus, Science Policy, EFPIA Ljubljana, 23 May 2014

International. Recruiting Briefing

Lithuanian R&D&I potential

OUR MISSION OUR EXPERTISE OUR SERVICES

QPS Neuropharmacology Overview

CHAPTER 4. Milestones of the drug discovery

GUIDELINES FOR REGISTRATION OF IMPORTERS AND FOR THE IMPORTATION OF MEDICINES AND RELATED PRODUCTS

Public Assessment Report. Scientific discussion. Natriumfusidat LEO 30 mg/100 cm 2 impregnated dressing. (Sodium fusidate) DK/H/2431/001/DC

S9 Nonclinical Evaluation for Anticancer Pharmaceuticals

TECHNOLOGIES & SERVICES FOR THERAPEUTIC ANTIBODY DEVELOPMENT

Annex 2: Registration Categories and Application Information Requirements of Chemical Drugs

to The Uganda Gazette No. 18 Volume CVII dated 28th March, 2014 Printed by UPPC, Entebbe, by Order of the Government No. 29.

Santara Valley experience in new health technologies. Vladas Algirdas Bumelis

of Innovative Pharmaceuticals* and Takao Inoue 4

Transcription:

1 INTEGRATED STUDIES, SCIENCE AND BUSINESS VALLEY SANTAKA CENTRE FOR THE ADVANCED PHARMACEUTICAL AND HEALTH TECHNOLOGIES www.lsmuni.lt

2

3 About Lithuanian University of Health Sciences Lithuanian University of Health Sciences is the largest institution of higher education for biomedical sciences in Lithuania, that was established in 2010, merging Kaunas Medical University and Lithuanian Veterinary Academy, and continuing the best studies and sciences traditions of the previous institutions that reach as far as year 1920. LUHS consists of two main divisions: Medical Academy, including five faculties (Medicine, Odontology, Pharmacy, Public Health and Nursing) and four scientific institutes (Behavioral Medicine, Endocrinology, Cardiology and Neuroscience), and Veterinary Academy, including two faculties (Veterinary Medicine and Animal Husbandry Technology) and two scientific institutes (Animal Husbandry as well as Microbiology and Virology). Study programs at LUHS include spheres of biomedical sciences (medicine and health, life sciences, agriculture and veterinary sciences) and social sciences (social studies, business and management sciences). LUHS award qualification degrees of all levels (bachelor, master, doctor) and provide professional qualifications in medicine, odontology, pharmacy, nursing, rehabilitation and veterinary medicine, as well as animal husbandry technology. Some of the study programs are conducted in the English and Russian languages. LUHS also offers post-graduate studies and provides a range of education and consultancy services. LUHS carries out research in biomedical sciences, agriculture, humanities and social sciences, the results of which are published in high ranking international journals and implemented in practice, prepares researchers in biomedicine and agriculture, performs research on demand of economic entities and take part in international projects. Together with other higher education institutions and companies of Lithuania LUHS took part in development of two integrates centres (valleys) of science, studies and business: Santaka Valley and Nemunas Valley. New infrastructure of science, studies and business that received more than 57million investment from the European Union funding and the budget of the Republic of Lithuania operates on the open access principle resulting in possibilities of viable cooperation between Lithuanian and foreign scientists and businessmen. LUHS is the founder of three public enterprises, of which the most important the largest in Lithuania multiprofile health care institution - The Hospital of Lithuanian University of Health Sciences (LUHS) Kauno klinikos, which consists of 36 profile clinics and 15 outpatient clinics (polyclinics). The Hospital of LUHS, provides clinical services, participates in the education and training of medical and other professionals. It is involved in joint research projects, applied scientific advances in medical practice and provides personal medical care. LUHS also founded the Lithuanian University of Health Sciences School and Practical Training and Testing Centre (for the disciplines of Veterinary Academy). More information on: www.lsmuni.lt

4 About the Santaka valley Centre for the Advanced Pharmaceutical and Health technologies Santaka valley Centre for the Advanced Pharmaceutical and Health technologies (further- center) is a modern six story laboratory facility consisting of departments of Faculty of pharmacy, laboratories and classrooms, performing fundamental and applied biomedical research, R& D, business orders. The center was established together with partners (Kaunas University of Technology, Lithuanian Energy Institute, Achemos grupė, MG Baltic Investiment, Kauno tiltai ) in accordance to the Development Programme of the Integrated Science, Studies and Business Centre (Valley) Santaka, to establish a valley of the Confluence for public and private research to knowledge-intensive business setting and the provision of value-added, knowledge-intensive services in these areas: sustainable chemistry, biopharmaceuticals, mechatronics and associated electric technologies, future energy (including environmental engineering) IT and telecommunication technologies. Co-funding by the European Union and the Republic of Lithuania budget for the establishment of Santaka valley R&D infrastructure is more than 64 mln. euros*. LUHS share of the funds, dedicated for the establishment of the center more than 15 mlm. euros. More information about the integrated science, studies and business center Santaka : www.santakosslenis.lt, www.smm.lt *The founding of Santaka valley Centre for the Advanced Pharmaceutical and Health technologies was financed according to 2007-2013 Economic development action program 1 priority Scientific research and technological development for the growth and increased competitiveness of the economy VP2-1.1-ŠMM-04-V tool Enforcement of the general science and studies infrastructure

5 Departments of Santaka valley Centre for the Advanced Pharmaceutical and health technologies: DEPARTMENT OF DRUG TECHNOLOGY AND SOCIAL PHARMACY (FACULTY OF PHARMACY, LUHS) The department performs physical and chemical research of semi-solid drug carrier forms, in order to determine the optimal characteristics for drug carriers and evaluate their influence on the kinetics of drug release. In vitro models are applied for research of drug release and penetration through skin. In vitro models of isolated skin are applied for research of chemical substances penetration through skin as well. These kinds of methods are used for safety and effectiveness research of medical substances and additives used in pharmaceutical technology. This method is widely accepted as the suitable method for evaluation of new topical medicines, new cosmetic substances and cosmetic products. Main areas of research: Studies of biological activity of natural and synthetic pharmaceutical preparations and additives in order to identify their possible biological target and to clarify their mechanisms of action; Studies and evaluation of transdermal substances. Production and evaluation of semi-solid drug forms. Identification of antioxidants and evaluation of their activity. A study on the integration of the elements of pharmaceutical care into pharmacy quality management systems. Research on the history of Lithuanian and the world s pharmacy. A study on medicinal substances and treatment techniques used in Lithuanian folk medicine. A study on the possibilities for increasing effectiveness of the activity of pharmacies on the basis of the analysis of new drug technologies, pharmacological services, pharmacoeconomics and pharmacoepidemiology. DEPARTMENT OF CLINICAL PHARMACY (FACULTY OF PHARMACY, LUHS) The department specializes in research of the clinical aspects of safe and efficient application of medicinal products. Main areas of research activities: The assessment and optimization of drug application for effective and rational medicinal therapy. This wide area of research includes research of number of medicines used for therapeutical purposes, in order to objectively evaluate the factors that may influence the effectiveness of the therapy. Specific ways to positively influence the effectiveness of therapeutic methods are identified, the factors that increase the risks of administered drugs are determined. Research of drug biopahmaceutical characterization, pharmacokinetics, and their therapeutical monitoring, to ensure safe administration of drugs, when personal features of patients are assessed.

6 DEPARTMENT OF DRUG CHEMISTRY (FACULTY OF PHARMACY, LUHS) The subject of the research of the department is synthesis, analysis and investigation of the action of biologically active compounds in living organisms. Main areas of activity: Synthesis and analysis of biologically active compounds with antifungal, antimicrobial, antituberculosis and anticancer properties. Investigation of the relation between chemical structure and pharmacological activity Research of the metabolism of medical substances, identification and extraction of the resulting metabolites. Investigation of the relation between chemical structure and pharmacological activity and selection of the most effective compounds for preclinical research. DEPARTMENT OF ANALYTICAL AND TOXICOLOGICAL CHEMISTRY (FACULTY OF PHARMACY, LUHS) The main objectives of the department of analytical and toxicological chemistry is to promote the development of modern analytical methods in toxicology, pharmacokinetics, quality assessment of natural herbal substances; to develop chemical analysis methods for scientific and industrial use; to develop methods for the analysis of impurities, metabolites and other toxins of various origin; to conduct scientific projects of high quality; to perform contract research. Main areas of activity: Pharmacokinetic studies of medicinal and toxic compounds in vitro, development and optimization of methodologies; Pharmacokinetic studies of medicinal and toxic compounds in vivo according to existing methodologies; Analysis of biologically active substances, heavy metals and pesticides in medicinal products according to validated or official methodology Development of validated methodologies for the quantitative analysis of biologically active materials in biological objects. Investigation and validation of analysis methodologies for the determination of drugs in biological objects; Development of methodologies for the detection of metabolites of biologically active substances Drug stability analysis (development of analytical methods, identification of factors influencing stability and products that form during deterioration). Characterization of drug physical forms and its application in quality systems of pharmaceutical products.

7 DEPARTMENT OF PHARMACOGNOSY (FACULTY OF PHARMACY, LUHS) The scientific work area of the Department involves investigations into the chemical research of plant origin raw materials and herbal preparations. The department analyses samples of herbal materials to evaluate the qualitative and quantitative composition of the biologically derived substances. Main areas of activities: Quality control of medical herbal materials using modern scientific methods Selection of analytical and biologicaly active markers for quality control of food supplements and herbal medicinal materials. Development of new analytical methods, optimisation and legislation of the existing ones for the quality control of herbal raw materials, medicinal products and food supplements. Impurities analysis in herbal materials LABORATORY OF PHYTOPHARMACY (FACULTY OF PHARMACY, LUHS) The laboratory performs research of herbal raw materials, medicinal compounds and other plant derived products. Purification of herbal products, their analysis and research of biological activity and other pharmaceutical research is done at the laboratory. The lab strives to be the competence center for herbal medicinal products scientific research and form directions for establishing new technologies. Main areas of activities: Chemical analysis of multicomponent plant derived materials using modern research methods Developing high-technology based qualitative and quantitative analysis methods for herbal medicinal materials and herbal extracts Research of biodiversity and studies of accumulation patterns of biologically active substances in medicinal plants Quantitative analysis of biologically active substances, accompanying materials and toxic substances in herbal medicinal materials, as well as determination of quantitative criteria and developing new standardization methods. Developing methodologies for testing complicate samples, extracting biologically active substances, their purification and identification. Identification of quality control parameters in herbal medicines and their scientific justification. Implementation of the developed qualitative and quantitative analysis methods in industrial plants. Cooperation with business partners in new product development (using new herbal materials, new extraction methods for biologically active compounds). Standardization and normalization of extracts and preparations according to quantitative parameters of bioactive markers Chemical and bio-equivalence analysis of phytopreparations, safety tests of raw materials and preparations, bioactivity tests.

8 LABORATORY OF PHARMACEUTICAL TECHNOLOGY (FACULTY OF PHARMACY, LUHS) Pharmaceutical technology research of technical aspects of separation and purification of peptide ant protein materials are done by the laboratory. New drug forms using peptides and proteins are being developed, as well as their chemical and physical characterization methods, using stability, safety, effectiveness tests that are compliant with requirements of international drug agencies. Main areas of activities: Biopharmaceutical testing of drugs and pharmaceutical formulations, including cellular models and tissue penetration studies. Studies of biologically active peptides and proteins, developing their separation and purification technologies, that don t influence their therapeutic potency. Formulation of peptide and protein dosage forms, and their stability and bioavailability testing. LABORATORY OF PRECLINICAL DRUG INVESTIGATION (INSTITUTE OF CARDIOLOGY, LUHS) The laboratory does practical tests of new drug Main areas of activities: forms, technologies and methods, that are necessary Preclinical trials of new medical substances for the development of new treatment Research on joint cartilage engineering using synthetic matrices methods and new products. Research on artificial heart valve engineering using synthetic matrices LABORATORY OF MEDICAL TARGET HISTOPATHOLOGICAL RESEARCH (INSTITUTE OF CARDIOLOGY, LUHS) The laboratory contains unique medical equipment in Lithuania, that allows to employ all mod- To define molecular criteria for myocardial damage of various levels Main areas of research: ern in situ molecular research technologies for and their diagnosis methods as plausible targets for treatment. Identification of various gene expression alterations in cardiac tisbiological tissues. A complex biological images sues research on extraction and preservation of RNA. analysis center is established in the laboratory, which performs tests that require high definition fully automatic microscopy systems.

9 LABORATORY OF DRUG METABOLISM AND PHARMACOLOGICAL REGULATION OF PATHOLOGICAL PROCESSES (Institute of Neuroscience) The laboratory investigates effects of medicines and other potential pharmacological substances on functions of experimental animal organs, tissues, cells and organelles, evaluating molecular mechanisms of their action in various pathologies as well as testing possible toxic effects of the studied materials on cells and subcellular components. Various methods of biochemistry, molecular biology, preoteomics and molecular toxicology are applied. Main areas of activities: Development of new methods for early diagnostics of Alzheimer s disease; In vitro testing of pharmacological substances for prevention and treatment of neurodegenerative diseases using neuronal cell cultures; Investigations of the cellular antioxidant system and modulation of its activity with potential medicinal substances and food supplements. Studies on the effects of food supplements, antibacterial and anticancer drugs on functioning of ocular system; Evaluation of the effects of plant-derived biologically active immunomodulators in various experimental models of pathological processes; Studies of toxic effects of heavy metals and other environmental pollutants using experimental animal models. UNIVERSITY PHARMACY In addition to providing medicines manufacturing services to the public, LUHS University pharmacy acts as a training facility for 5th year students of Faculty of Pharmacy as well as foreign students studying pharmacy and foreign Exchange program students. Pharmacy specialists individually manufacture prescribed medicines for patients whether that is traditional medicine or homeopathy. University pharmacy operates industrial production line of medicinal cosmetics (creams, ointments and other), the products are certified and may be sold in Lithuania and abroad. The pharmacy experts consult scientists, business enterprises and developers of new medicines on the technological possibilities to produces pilot scale production runs of the medicines or cosmetics. More on the University Pharmacy go to the website www.lsmuvaistine.lt

10 Services provided by the departments of Open Access Center*: Quality control of herbal pharmaceuticals. Determination of therapeutically active analytical markers in herbal materials for quality control Developing new and optimizing existing analytical methods for legal approval. Quantitative and qualitative analysis of impurities in herbal materials and herbal products. Preclinical trials for newly developed drugs Research on joint cartilage engineering using synthetic matrices Research on artificial heart valve engineering using synthetic matrices Tissue preparation using immunohistochemical reactions for morphometric analysis. Evaluation of biomarkers expression in immunohistochemical reactions, morphometric evaluation and full analysis scale. Preparation of tissues for microscopic and morphometric analyses in hybridization reactions. Evaluations of biomarkers expression Research on pharmacological and chemical materials cytotoxicity (neurotoxicity). Research of cell antioxidation system and it s modulation with potential medical preparations and food supplements. Biopharmaceutical testing and evaluation of dosage forms Development and stability testing of peptide and protein drug forms Research of drug absorption through/into skin Laboratorial analysis of creams and ointments Research and analysis of physical and chemical properties of polymeric materials. Determination and analysis of tablet solubility, hardness and friability. Production of extracts Qualitative and quantitative analysis of drug substances Pharmacokinetic research Development of HPLC analytical methods for herbal material and herbal drugs. Analysis of biologically active compounds Synthesis of biologically active compounds Quantitative and qualitative evaluation of organic solvents, volatile poisonous materials, pesticides. Validated HPLC analysis of various samples. Quality analysis of various samples by HPLC methods. *Other custom services may be provided accordingly to an agreement. Services are provided using the principle of Open Access.

11 You can find the Santaka valley Centre for the Advanced Pharmaceutical Health and Technologies at: 1. Centre for the Advanced Pharamceutical and Health Technologies 2. Learning and laboratory centre 3. LUHS library 4. LUHS Institute of Cardiology

Lithuanian University of Health Sciences contacts: A. Mickevičiaus g. 9 Kaunas, LT-44307 Lietuva Tel.: (+370 37) 327201 Fax: (+370 37) 220733 Email.: rektoratas@lsmuni.lt www.lsmuni.lt More information on Santaka valley: Eivenių g.4, Kaunas, LT-50161 Lietuva Tel.: (+370 37) 36 25 56 Email.: apc@lsmuni.lt www.santakosslenis.lt